Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies

J Virol. 1999 Nov;73(11):9369-76. doi: 10.1128/JVI.73.11.9369-9376.1999.

Abstract

The nucleotide sequence of human T-cell leukemia virus type 1 (HTLV-1) is highly conserved, most strains sharing at least 95% sequence identity. This sequence conservation is also found in the viral env gene, which codes for the two envelope glycoproteins that play a major role in the induction of a protective immune response against the virus. However, recent reports have indicated that some variations in env sequences may induce incomplete cross-reactivity between HTLV-1 strains. To identify the amino acid changes that might be involved in the antigenicity of neutralizable epitopes, we constructed expression vectors coding for the envelope glycoproteins of two HTLV-1 isolates (2060 and 2072) which induced human antibodies with different neutralization patterns. The amino acid sequences of the envelope glycoproteins differed at four positions. Vectors coding for chimeric or point-mutated envelope proteins were derived from 2060 and 2072 HTLV-1 env genes. Syncytium formation induced by the wild-type or mutated envelope proteins was inhibited by human sera with different neutralizing specificities. We thus identified two amino acid changes, I173-->V and A187-->T, that play an important role in the antigenicity of neutralizable epitopes located in this region of the surface envelope glycoprotein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology*
  • Cell Line
  • Cytopathogenic Effect, Viral
  • Genes, env / genetics
  • Giant Cells / physiology
  • Glycoproteins / chemistry
  • Glycoproteins / genetics
  • Glycoproteins / immunology*
  • Human T-lymphotropic virus 1 / chemistry
  • Human T-lymphotropic virus 1 / genetics
  • Human T-lymphotropic virus 1 / immunology*
  • Human T-lymphotropic virus 1 / physiology
  • Humans
  • Neutralization Tests
  • Point Mutation
  • Recombinant Fusion Proteins / immunology
  • Transfection
  • Viral Envelope Proteins / chemistry*
  • Viral Envelope Proteins / genetics
  • Viral Envelope Proteins / immunology*

Substances

  • Antibodies, Viral
  • Glycoproteins
  • Recombinant Fusion Proteins
  • Viral Envelope Proteins

Associated data

  • GENBANK/AF029075